ARCT in the 13F filings
Arcturus Therapeutics LTD · CUSIP 03969T109
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 21
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 1 listed it in both
- Shares listed
- 6,340,385
- combined, among listed positions
- Reported value
- $43m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 13 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +530,698.
Managers listing ARCT in Q2 2026
21 of 21 holders
Largest increases and reductions, by shares
Increases
- AQR Capital Management LLCexisting position · 675,014 shares now+513,736
- Point72 Asset Management LPexisting position · 231,582 shares now+167,737
- D. E. Shaw & Co.existing position · 392,358 shares now+140,324
- ARK Investment Management LLCexisting position · 2,901,635 shares now+132,117
- Marshall Wace LLPnew position · 77,269 shares now+77,269
Reductions
- Renaissance Technologies LLCexisting position · 21,400 shares now-156,900
- Susquehanna International Group LLPexisting position · 47,557 shares now-156,457
- Acadian Asset Management LLCexisting position · 131,451 shares now-149,049
- Millennium Management LLCexisting position · 336,996 shares now-141,561
- Invesco Ltdexisting position · 104,188 shares now-9,382
New positions and exits
New (3)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2019 | 1 | $9.5m | n.a. | n.a. |
| Q3 2019 | 1 | $13m | n.a. | n.a. |
| Q4 2019 | 1 | $15m | n.a. | n.a. |
| Q1 2020 | 1 | $21m | n.a. | n.a. |
| Q2 2020 | 3 | $107m | n.a. | n.a. |
| Q3 2020 | 5 | $129m | n.a. | n.a. |
| Q4 2020 | 1 | $172m | n.a. | n.a. |
| Q1 2021 | 3 | $150m | n.a. | n.a. |
| Q2 2021 | 1 | $98m | n.a. | n.a. |
| Q3 2021 | 3 | $128m | n.a. | n.a. |
| Q4 2021 | 2 | $93m | n.a. | n.a. |
| Q1 2022 | 3 | $77m | n.a. | n.a. |
| Q2 2022 | 3 | $61m | n.a. | n.a. |
| Q3 2022 | 2 | $45m | n.a. | n.a. |
| Q4 2022 | 2 | $47m | n.a. | n.a. |
| Q1 2023 | 2 | $67m | n.a. | n.a. |
| Q2 2023 | 2 | $85m | n.a. | n.a. |
| Q3 2023 | 3 | $76m | n.a. | n.a. |
| Q4 2023 | 4 | $111m | 2 | 1 |
| Q1 2024 | 4 | $100m | 1 | 3 |
| Q2 2024 | 3 | $73m | 1 | 3 |
| Q3 2024 | 4 | $77m | 4 | 0 |
| Q4 2024 | 4 | $62m | 3 | 1 |
| Q1 2025 | 3 | $38m | 1 | 2 |
| Q2 2025 | 3 | $43m | 0 | 2 |
| Q3 2025 | 2 | $47m | 1 | 1 |
| Q4 2025 | 1 | $16m | 13 | 12 |
| Q1 2026 | 1 | $21m | 12 | 8 |
| Q2 2026 | 1 | $19m | 13 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ARCT and LLY →ARCT and JNJ →ARCT and VRTX →Choose a stock to compare with ARCT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ARCT, latest filings →Back to the 13F Explorer →